Detalles de la búsqueda
1.
New Perspectives on Antimicrobial Agents: Imipenem-Relebactam.
Antimicrob Agents Chemother
; 66(7): e0025622, 2022 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35727059
2.
Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers.
Antimicrob Agents Chemother
; 66(12): e0093522, 2022 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36394316
3.
Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults.
Antimicrob Agents Chemother
; 66(12): e0093622, 2022 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36394326
4.
Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia.
Antimicrob Agents Chemother
; 65(6)2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33753337
5.
The Pharmacodynamic-Toxicodynamic Relationship of AUC and Cmax in Vancomycin-Induced Kidney Injury in an Animal Model.
Antimicrob Agents Chemother
; 65(3)2021 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33318004
6.
Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships.
Antimicrob Agents Chemother
; 65(10): e0106021, 2021 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34339278
7.
Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.
Antimicrob Agents Chemother
; 63(7)2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30988153
8.
Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.
J Antimicrob Chemother
; 74(8): 2326-2334, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31065686
9.
Prevalence of a Cefazolin Inoculum Effect Associated with blaZ Gene Types among Methicillin-Susceptible Staphylococcus aureus Isolates from Four Major Medical Centers in Chicago.
Antimicrob Agents Chemother
; 62(8)2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29891607
10.
Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis.
Crit Care Med
; 46(2): 236-243, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29116995
11.
Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins.
J Antimicrob Chemother
; 73(10): 2643-2651, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30085140
12.
24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.
Antimicrob Agents Chemother
; 61(11)2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28807910
13.
Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing.
J Infect Chemother
; 23(5): 326-332, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28109741
14.
Tree-Based Models for Predicting Mortality in Gram-Negative Bacteremia: Avoid Putting the CART before the Horse.
Antimicrob Agents Chemother
; 60(2): 838-44, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26596934
15.
Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.
Antimicrob Agents Chemother
; 60(10): 5742-51, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27431226
16.
Correction for Rhodes et al., Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.
Antimicrob Agents Chemother
; 61(4)2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28341810
17.
In vitro activity of imipenem/relebactam plus aztreonam against metallo-ß-lactamase-producing, OprD-deficient Pseudomonas aeruginosa with varying levels of Pseudomonas-derived cephalosporinase production.
Int J Antimicrob Agents
; 59(6): 106595, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35483625
18.
Impact of early antimicrobial stewardship intervention in patients with positive blood cultures: results from a randomized comparative study.
Int J Antimicrob Agents
; 59(2): 106490, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34871745
19.
Treatment of patients with serious infections due to carbapenem-resistant Acinetobacter baumannii: How viable are the current options?
Pharmacotherapy
; 41(9): 762-780, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34170571
20.
Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection.
Int J Antimicrob Agents
; 57(4): 106311, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33621602